TCL Archive NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says By Cancer History Project June 5, 1992
TCL Archive Chabner Criticizes FDA Crackdown On Off-Label Info By Cancer History Project June 28, 1991
TCL Archive Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split By Cancer History Project April 5, 1991
TCL Archive Chabner, FDA’s Temple continue disagreement Over Drug Approval By Cancer History Project February 10, 1989
TCL Archive In Brief: Vietti Heads Chairman’s Committee; Chabner Seeks Deputy Candidates; WHO Centers At MSK By Cancer History Project December 2, 1988
TCL Archive FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced By Cancer History Project November 4, 1988
TCL Archive FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay By Cancer History Project October 21, 1988
TCL Archive In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman By Cancer History Project September 2, 1988
ArticleSpotlight Article Before her legendary career at NIH, Vivian Pinn was the second Black woman to graduate from UVA med school By Cancer History Project
ArticleSpotlight Article Roderic Pettigrew, founding director of NIBIB, reflects on a career as a “physicianeer”—merging medicine, engineering By Cancer History Project